Bumrungrad Hospital Public Company Limited
BUHPF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $6,513 | $6,024 | $6,141 | $6,473 |
| % Growth | 8.1% | -1.9% | -5.1% | – |
| Cost of Goods Sold | $3,061 | $2,864 | $3,040 | $3,259 |
| Gross Profit | $3,452 | $3,160 | $3,101 | $3,214 |
| % Margin | 53% | 52.5% | 50.5% | 49.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $890 | $821 | $920 | $953 |
| SG&A Expenses | $1,056 | $961 | $1,084 | $1,142 |
| Sales & Mktg Exp. | $167 | $140 | $164 | $189 |
| Other Operating Expenses | -$66 | -$80 | -$65 | -$53 |
| Operating Expenses | $990 | $882 | $1,019 | $1,089 |
| Operating Income | $2,462 | $2,279 | $2,083 | $2,125 |
| % Margin | 37.8% | 37.8% | 33.9% | 32.8% |
| Other Income/Exp. Net | $49 | $50 | $61 | $63 |
| Pre-Tax Income | $2,511 | $2,328 | $2,144 | $2,189 |
| Tax Expense | $464 | $449 | $400 | $279 |
| Net Income | $2,035 | $1,858 | $1,734 | $1,903 |
| % Margin | 31.2% | 30.8% | 28.2% | 29.4% |
| EPS | 2.56 | 2.34 | 2.18 | 2.2 |
| % Growth | 9.4% | 7.3% | -0.9% | – |
| EPS Diluted | 2.35 | 2.14 | 2 | 2.19 |
| Weighted Avg Shares Out | 795 | 795 | 795 | 866 |
| Weighted Avg Shares Out Dil | 867 | 867 | 867 | 867 |
| Supplemental Information | – | – | – | – |
| Interest Income | $50 | $52 | $63 | $66 |
| Interest Expense | $1 | $2 | $2 | $2 |
| Depreciation & Amortization | $269 | $259 | $256 | $275 |
| EBITDA | $2,781 | $2,590 | $2,402 | $2,465 |
| % Margin | 42.7% | 43% | 39.1% | 38.1% |